Your browser doesn't support javascript.
loading
[Drug treatment of osteonecrosis]. / Medikamentöse Therapie von Osteonekrosen.
Roth, Andreas; Maus, Uwe.
Afiliação
  • Roth A; Klinik und Poliklinik für Orthopädie, Unfallchirurgie und Plastische Chirurgie, Bereich Endoprothetik/Orthopädie, Universitätsklinikum Leipzig AöR, Liebigstr. 20, Haus 4, 04103, Leipzig, Deutschland. andreas.roth@medizin.uni-leipzig.de.
  • Maus U; Klinik für Orthopädie und Unfallchirurgie, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland.
Orthopadie (Heidelb) ; 51(10): 783-791, 2022 Oct.
Article em De | MEDLINE | ID: mdl-36074164
ABSTRACT
The medicinal treatment of osteonecrosis is described as part of the conservative treatment for atraumatic femoral head necrosis of the hip in adults and for Ahlbäck's disease of the knee joint. For femoral head necrosis, iloprost is used in the early stages (ARCO I and II) as a treatment attempt to eliminate pain and the accompanying bone marrow edema. This also applies to the use of bisphosphonates, whereby preferably small defects (< 30%) are suitable for treatment. Bisphosphonates are successfully used in the knee joint to treat Ahlbäck's disease, although the results are sometimes contradictory. Other locations, such as the humeral head, talus, scaphoid, lunate, proximal tibia, and metatarsal head, are sometimes successfully treated with bisphosphonates. Although the results seem promising, the groups are far too small to derive treatment recommendations in this regard.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Necrose da Cabeça do Fêmur Idioma: De Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Necrose da Cabeça do Fêmur Idioma: De Ano de publicação: 2022 Tipo de documento: Article